Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01983982 · ClinicalTrials.gov registry record
Effect of Chemotherapy on Pain Sensitivity and Patient-reported Symptoms
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 30
- Enrollment target
NCT01983982: Completed study, sponsored by University of Michigan.
NCT01983982 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01983982 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Many breast cancer survivors report chronic pain that develops or worsens following chemotherapy. The impact of chemotherapy on the development of chronic pain is uncertain. In this proposal, we are studying the impact of chemotherapy on a patient's sensitivity to pain. We are also investigating whether a patient's sensitivity to pain is related to how many symptoms she experiences during treatment.
Primary Outcome
Feasibility will be measured by the proportion of women who complete the post-chemotherapy assessment among those consenting to participate in the trial.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-11 |
| Est. Completion | 2016-01 |
What the finished NCT01983982 record still lists
NCT01983982 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01983982 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01983982 about?
NCT01983982 is a clinical study titled "Effect of Chemotherapy on Pain Sensitivity and Patient-reported Symptoms". Many breast cancer survivors report chronic pain that develops or worsens following chemotherapy. The impact of chemotherapy on the development of chronic pain is uncertain. In this proposal, we are studying the impact of chemotherapy on a patient's sensitivity to pain. We are also investigating whe...
What is the current status of trial NCT01983982?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2013-11. Estimated completion is 2016-01.
Who is sponsoring clinical trial NCT01983982?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia